±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 297  |  »Ø¸´: 6
¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û5´Î£¬×÷Õßlihai0910Ôö¼Ó½ð±Ò 3.75 ¸ö
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

lihai0910

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)


[×ÊÔ´] Reverse Transcriptase Inhibitors in HIV/AIDS Therapy

Reverse Transcriptase Inhibitors in HIV/AIDS Therapy (Infectious Disease)
By Gail Skowron


Publisher:  Humana Press
Number Of Pages:  544
Publication Date:  2006-05-01
ISBN / ASIN:  1588296490



--------------------------------------------------------------------------------

Book Description:

A magisterial survey of all aspects of the reverse transcriptase inhibitors (RTIs) used to treat HIV/AIDS, including drug discovery, pharmacology, development of drug resistance, toxicity, and prevention of mother-to-child transmission of HIV/AIDS. The authors synthesize our current understanding of the role of reverse transcriptase in the viral life cycle, describe the discovery and development of eight nucleoside and nucleotide analogs that represent milestones in treatment history, and thoroughly discuss the question of toxicity and resistance to this class of drugs. They also address three non-nucleoside RTIs and their pharmacokinetics and comparative clinical efficacy, new RTIs currently under development, and the impact of approved agents on treatment, in general, and on vertical transmission in the developing world.

1 Structural Studies on HIV Reverse Transcriptase
Related to Drug Discovery
David K. Stammers, PhD and Jingshan Ren, PhD......................... 1
2 Zidovudine, Lamivudine, and Abacavir
Monica Carten, MD and Harold Kessler, MD ............................. 33
3 Stavudine, Didanosine, and Zalcitabine
Gail Skowron, MD, Sapna Chowdhry, MD,
and Michael R. Stevens, PharmD ............................................... 77
4 Emtricitabine
Gail Skowron, MD, Jeffrey Bratberg, PharmD, BCPS,
and Rudi Pauwels, PhD ........................................................... 133
5 Nucleotide Analogs
Craig J. Hoesley, MD .................................................................... 157
6 Resistance to Nucleoside and Nucleotide Reverse
Transcriptase Inhibitors
Nancy Shulman, MD and Mark Winters, MS ........................... 179
7 Pharmacokinetics of Reverse Transcriptase Inhibitors
Patrick Hoggard, PhD, Stephen Kewn, PhD,
Saye Khoo, MD, PhD, and David Back, PhD ........................... 209
8 Peripheral Neuropathy Associated With Nucleoside
Reverse Transcriptase Inhibitor Therapy
Bruce A. Cohen, MD and Russell Bartt, MD .............................. 237
x Contents
9 Mitochondrial Dysfunction and Nucleoside Reverse
Transcriptase Inhibitor Therapy:
A Pathophysiological Perspective
William Lewis, MD....................................................................... 267
10 Mitochondrial Toxicity and Lipodystrophy
Grace McComsey, MD .................................................................. 281
11 Nevirapine
David Asmuth, MD, and Richard Pollard, MD......................... 303
12 Efavirenz
Graeme J. Moyle, MD, MBBS and Brian Conway, MD............... 345
13 Delavirdine
Brian Conway, MD ....................................................................... 375
14 Resistance to Non-Nucleoside Reverse Transcriptase
Inhibitors
F. Ramzi Asfour, MD and Richard Haubrich, MD.................... 401
15 Vertical Transmission of HIV and Therapeutic
Interventions
Susan Cu-Uvin, MD, Arlene Bardeguez, MD, MPH,
and Carla Chibwesha, MSc ........................................................ 425
16 New Reverse Transcriptase Inhibitors in Development
Rudi Pauwels, PhD ....................................................................... 471
17 Antiretroviral Drugs for Millions
Allan Ronald, MD, Elly Katabira, MBBS,
and Merle Sande, MD ............................................................... 499
Postscript
Richard Ogden, PhD and Gail Skowron, MD ............................ 515
Index .............................................................................................. 517
http://www.91files.com/?1F8M6R8UA4PHFW5YMAPJ
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sofia311


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

лл·Ç³£
2Â¥2007-10-30 15:34:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yinjj

½ð³æ (Ö°Òµ×÷¼Ò)


¡ï¡ï¡ï ÈýÐǼ¶,Ö§³Ö¹ÄÀø

3Â¥2007-10-31 15:47:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zpp0327

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶,ÓÅÐãÍÆ¼ö

4Â¥2007-11-01 14:52:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ lihai0910 µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á +9 ¹þ¹þ¹þ¶ì¹þ¹þ¹þ 2026-04-05 9/450 2026-04-05 22:24 by dongzh2009
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +4 ´Þwj 2026-04-05 4/200 2026-04-05 20:29 by à£à£à£0119
[¿¼ÑÐ] 08ר˶275µ÷¼Á +5 AaAa7420 2026-04-05 5/250 2026-04-05 18:01 by jkddd
[¿¼ÑÐ] 313Çóµ÷¼Á +5 º£ÈÕº£ÈÕ 2026-04-04 7/350 2026-04-05 13:58 by imissbao
[¿¼ÑÐ] 085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á +6 ²ÐÐÇ·÷Êï 2026-03-31 6/300 2026-04-05 12:15 by rainbow11
[¿¼ÑÐ] Çóµ÷¼Á +4 wos666 2026-04-03 4/200 2026-04-05 11:48 by arrow8852
[¿¼ÑÐ] 295Çóµ÷¼Á +4 AÄãºÃÑо¿Éú 2026-04-04 5/250 2026-04-04 22:46 by yu221
[¿¼ÑÐ] 333Çóµ÷¼Á +12 wfh030413@ 2026-04-03 13/650 2026-04-04 21:02 by jj987
[¿¼ÑÐ] Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-04 3/150 2026-04-04 12:19 by Éá¶øºóµÃ
[¿¼ÑÐ] 266Çóµ÷¼Á +18 ÑôÑôÍÛÈû 2026-04-01 18/900 2026-04-03 18:38 by zllcz
[¿¼ÑÐ] 293Çóµ÷¼Á +5 ĩδmm 2026-04-02 6/300 2026-04-03 15:20 by Íõ±£½Ü33
[¿¼ÑÐ] ÉúÎïѧÇóµ÷¼Á +3 15064154688 2026-04-03 3/150 2026-04-03 10:28 by macy2011
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤µ÷¼Á£¬339 +14 10213207 2026-03-31 14/700 2026-04-02 21:01 by 1104338198
[¿¼ÑÐ] 26¿¼Ñе÷¼Á +4 Wnz.20030617 2026-04-01 5/250 2026-04-02 16:11 by 1939136013¹·×³
[¿¼ÑÐ] 311Çóµ÷¼Á +14 À¶ÔÂÁÁÁÁ 2026-03-30 14/700 2026-04-02 12:18 by 1753564080
[¿¼ÑÐ] ¿¼Ñе÷¼Á +12 Amber00 2026-03-31 12/600 2026-04-02 09:04 by sanrepian
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧ¼ÆËã»úר˶£¬³õÊÔ373£¬Áù¼¶Í¨¹ý£¬ +3 ¼ÆËã»ú×·ÃÎÈË 2026-04-01 3/150 2026-04-02 07:57 by fxue1114
[¿¼ÑÐ] 070300»¯Ñ§279Çóµ÷¼Á +15 ¹þ¹þ¹þ^_^ 2026-03-31 17/850 2026-04-01 21:37 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] ºÏ·ÊÇøÓòÐÔÖØµãÒ»±¾ÕÐÊÕµ÷¼Á +4 6266jl 2026-03-30 8/400 2026-03-31 18:43 by 6266jl
[¿¼ÑÐ] Çóµ÷¼Á ÉúÎïѧ 377·Ö +6 zzll03 2026-03-31 6/300 2026-03-31 17:33 by ÌÆãå¶ù
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û